Radiopharmaceuticals in Nuclear Medicine Market to Surpass US$ 11,504.8 Million by 2027

There are numerous radiopharmaceuticals available for both therapeutic and diagnostic purposes, each with distinct and overlapping indications for specific disorders like Alzheimer's (Vizamyl, Amyvid, and Neuraceq). There are around 50 radiopharmaceuticals with U.S. FDA approval available for both therapeutic and diagnostic uses, with Technetium alone having over 30 approved compounds.

Business Dynamics

In order to increase their market presence, industry players are focusing on a variety of inorganic growth tactics including partnership and cooperation agreements, which is anticipated to accelerate the growth of the worldwide radiopharmaceuticals in nuclear medicine market over the forecast period. For instance, a distribution contract was signed by Cardinal Health Inc. and Telix Pharmaceuticals Inc., a division of Telix Pharmaceuticals Limited, in October 2018. In accordance with the contract, Cardinal Health will provide the 69Ga-PSMA Kit as well as create unit dosages of 68Ga-PSMA delivered as an investigational product for use in clinical trials sponsored by qualified investigators, including those sponsored by Telix.

Important aspects of the study:

• Using 2019 as the base year, this research analyses the global market for radiopharmaceuticals used in nuclear medicine and offers market size (US$ Mn) and compound annual growth rate (CAGR%) for the projected period (2020–2027).

• It presents appealing investment proposition matrices for this industry and clarifies prospective revenue prospects across various categories.

• This research also offers important insights into market trends, opportunities, new product launches or approvals, market drivers, restraints, trends in regional markets, and competitive tactics used by prominent competitors.

Comments

Popular posts from this blog

Breast Pumps Market to Surpass US$ 1,211.6 Million with a CAGR of 4.6% by 2027

Enhancing Patient Security and Privacy: The Power of Healthcare Biometrics